AbstractPhotodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photosensitizing agent in combination with laser irradiation of a distinct wavelength. In some case reports and small non-randomized pilot studies, PDT has proved feasible in patients with hilar bile duct cancer. Those studies showed an astonishing long survival time of the treated patients. In the yet published two randomized controlled studies, PDT showed a significant extension of survival compared to sole bile duct stenting. A possible explanation for this improved survival is a suspected anti-tumor immunological effect induced by PDT. PDT reaches the same level of survival time as incomplete resection. The main complication is a high risk of ...
Background: The majority of patients with hilar cholangiocarcinoma have irresectable disease and req...
Prognosis of nonresectable cholangiocarcinoma is not good, and in Bismuth type III and IV tumors rel...
The results of the pilot study of combined treatment for non-resectable cholangiocarcinoma complicat...
AbstractPhotodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photo...
Hilar cholangiocarcinoma is a fatal malignancy leading to high mortality rate despite recent therape...
The prognosis of bile duct cancer (BDC) is limited due to tumor spread along the biliary tree leadin...
PURPOSE OF REVIEW: Photodynamic therapy (PDT) with hematoporphyrins has emerged as promising treatme...
Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time ...
Cholangiocarcinoma is a challenge to manage; mortality rate is nearly as high as the incidence. Unle...
Photodynamic therapy (PDT) is based on the activation of a photosensitizer by (laser) light to local...
The prognosis of nonresectable cholangiocarcinoma is dismal, and in Bismuth type III and IV tumors r...
Background/Aims: Patients with cholangiocarcinoma usu-ally present at an advanced stage, and more th...
The therapeutic and diagnostic modalities of light are well known, and derivative photodynamic react...
Cholangiocarcinoma is, in most cases, rapidly fatal. Curative resection can only be offered to appro...
AbstractBackgroundThe majority of patients with hilar cholangiocarcinoma have irresectable disease a...
Background: The majority of patients with hilar cholangiocarcinoma have irresectable disease and req...
Prognosis of nonresectable cholangiocarcinoma is not good, and in Bismuth type III and IV tumors rel...
The results of the pilot study of combined treatment for non-resectable cholangiocarcinoma complicat...
AbstractPhotodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photo...
Hilar cholangiocarcinoma is a fatal malignancy leading to high mortality rate despite recent therape...
The prognosis of bile duct cancer (BDC) is limited due to tumor spread along the biliary tree leadin...
PURPOSE OF REVIEW: Photodynamic therapy (PDT) with hematoporphyrins has emerged as promising treatme...
Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time ...
Cholangiocarcinoma is a challenge to manage; mortality rate is nearly as high as the incidence. Unle...
Photodynamic therapy (PDT) is based on the activation of a photosensitizer by (laser) light to local...
The prognosis of nonresectable cholangiocarcinoma is dismal, and in Bismuth type III and IV tumors r...
Background/Aims: Patients with cholangiocarcinoma usu-ally present at an advanced stage, and more th...
The therapeutic and diagnostic modalities of light are well known, and derivative photodynamic react...
Cholangiocarcinoma is, in most cases, rapidly fatal. Curative resection can only be offered to appro...
AbstractBackgroundThe majority of patients with hilar cholangiocarcinoma have irresectable disease a...
Background: The majority of patients with hilar cholangiocarcinoma have irresectable disease and req...
Prognosis of nonresectable cholangiocarcinoma is not good, and in Bismuth type III and IV tumors rel...
The results of the pilot study of combined treatment for non-resectable cholangiocarcinoma complicat...